Viewing nowCombinationTwin Beta Tablet 40/10 mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Daewoong Bio Co., Ltd.

MFDS item code 201702693 · Approved 2017.05.30 · Insurance code 694001400
Treatment of essential hypertension not controlled by monotherapy
Used for the treatment of essential hypertension when blood pressure is not adequately controlled with monotherapy with telmisartan or amlodipine.
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, a direct switch to this medicine may be considered if blood pressure is not adequately controlled with the individual components, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience of administration (only for this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (Refer to section “3. Patients who should be administered this medicine with caution.”) In patients 75 years and older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Administration of this medicine is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it can pose severe risks to the fetus. Administration is contraindicated in patients with a known allergy to this medication or similar medications, pregnant women, nursing mothers, and patients with serious liver or heart problems. Patients with impaired liver function, gastrointestinal diseases, reduced kidney function, elderly patients, etc., should use this medication with caution and consult with healthcare professionals. Since this medication lowers blood pressure, patients with hypotension should check their condition carefully before use, and if symptoms of hypotension occur, appropriate measures should be taken. There may be an increase in serum potassium levels, so caution is needed when taking with potassium-rich foods or other medications. This medication can interact with various drugs, so if you are taking other medications, be sure to inform your doctor or pharmacist. Common side effects such as dizziness, edema, headache may occur, and in severe cases, immediate consultation with medical personnel is required. Women who are pregnant or planning to become pregnant must consult with a healthcare professional before starting this medication, and if pregnancy is confirmed, it should be discontinued immediately. The safety and efficacy of this medication in children have not been established; therefore, it is not recommended for use in children. In case of overdose, severe hypotension or cardiac problems may occur, and immediate emergency treatment is required. This medication should be kept out of reach of children, and it is recommended to avoid transferring it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a tightly sealed container that can block light. Additionally, it is important to store it at room temperature between 1 to 30 degrees Celsius to maintain its effectiveness.
White and light blue, double convex oval-shaped tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.